Ayrıca, cerrahi pulmoner embolektominin en etkin tedavi yöntemlerinden biri olduğunu vurgulamaktadır.
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Otuz altı yaşında, çoklu trombojenik risk faktörüne sahip ve masif pulmoner emboli tablosu ile başvuran hastanın pulmoner embolektomi ile başarılı bir şekilde tedavi edilişini sunuyoruz.
📊
Temel Bulgular & Veri:Olgumuz pulmoner emboli de erken tanının önemini belirtmektedir.
💡
Sonuç & Katkı:Ayrıca, cerrahi pulmoner embolektominin en etkin tedavi yöntemlerinden biri olduğunu vurgulamaktadır.
Otuz altı yaşında, çoklu trombojenik risk faktörüne sahip ve masif pulmoner emboli tablosu ile başvuran hastanın pulmoner embolektomi ile başarılı bir şekilde tedavi edilişini sunuyoruz. Olgumuz pulmoner emboli de erken tanının önemini belirtmektedir. Ayrıca, cerrahi pulmoner embolektominin en etkin tedavi yöntemlerinden biri olduğunu vurgulamaktadır.
Abstract
We report a 36-year old woman who suffered from massive pulmonary embolism with multiple thrombogenic risk factors. She was successfully treated with pulmonary embolectomy. Our report reinforces the importance of early diagnosis in the presence of a high clinical suspicion for pulmonary embolism. Furthermore, surgical pulmonary embolectomy remains one of the most effective treatment methods.
FOTBOLCU, H., KAYA, E., BARUT, Y. D., IŞIK, Ö., YAKUT, C. (2018). Çoklu Trombojenik Risk Faktörüne Sahip Masif Pulmoner Emboli Olgusunun Başarılı Bir Şekilde Cerrahi Pulmoner Embolektomi ile Tedavisi: Olgu Sunumu. Koşuyolu Heart Journal, Cilt: 21 - Sayı: 1, 72–74. https://ajindex.com/articles/86487
Walther A, Böttiger BW. Pulmonary embolism. Wien Med Wochenschr 2008;158:610-4
Horlander KT, Mannino DM, Leeper KV. Pulmonary embolism mortality in the United States, 19791998: an analysis using multiplecause mortality data. Arch Intern Med 2003;163:1711-7
Goldhaber SZ. Pulmonary embolism. Lancet 2004;363:1295-305
Kline JA, Hernandez Nino J, Jones AE, Rose GA, Norton HJ, Camargo CA Jr. Prospective study of the clinical features and outcomes of emergency department patients with delayed diagnosis of pulmonary embolism. Acad Emerg Med 2007;14:592-8
Mullins MD, Becker DM, Hagspiel KD, Philbrick JT. The role of spiral volumetric computed tomography in the diagnosis of pulmonary embolism. Arch Intern Med 2000;160:293-8
Perrier A, Howarth N, Didier D, Loubeyre P, Unger PF, de Moerloose P, et al. Performance of helical computed tomography in unselected outpatients with suspected pulmonary embolism. Ann Intern Med 2001;135:88-97
Kujovich JL. Factor V Leiden thrombophilia. Genet Med 2011;13:1-16
Yusuf M, Gupta A, Kumar A, Afreen S. Mechanism and pathophysiology of activated protein C-related factor V leiden in venous thrombosis. Asian J Transfus Sci 2012;6:47-8
Ornstein DL, Cushman M. Cardiology patient page. Factor V Leiden. Circulation 2003;107:e94-7
Lauque D, Mazières J, Rouzaud P, Sié P, Chamontin B, Carrié D, et al. Pulmonary embolism in patients using estrogenprogestagen contraceptives. Presse Med 1998;27:15669
Lehmann R, Suess C, Leus M, Luxembourg B, Miesbach W, Lindhoff-Last E, et al. Incidence, clinical characteristics and longterm prognosis of travelassociated pulmonary embolism. Eur Heart J 2009;30:23341
Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/nonST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000;284:83542
Manzoli L, De Vito C, Marzuillo C, Boccia A, Villari P. Oral contraceptives and venous thromboembolism: a systematic review and metaanalysis. Drug Saf 2012;35:191205
Wu O, Robertson L, Twaddle S, Lowe GD, Clark P, Greaves M, et al. Screening for thrombophilia in highrisk situations: systematic review and costeffectiveness analysis. The thrombosis: risk and economic assessment of thrombophilia screening (TREATS) study. Health Technol Assess 2006;10:10010
Gruettner J, Viergutz T, Bolte M, Henzler T, Schoenberg SO, Sudarski S, et al. Importance of risk factors for the evaluation of